Search results
Governor reiterates desire for full financial support of West Virginians with disabilities - WV...
WV MetroNews· 7 days agoState officials acknowledged this week that in recent years West Virginia spent millions of dollars...
Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 days agoExact Sciences' (EXAS) first-quarter 2024 performance is expected to include gains from robust...
Vietnam Detains Parliament Chair’s Assistant as Builder Probed
Bloomberg via Yahoo News· 3 days ago(Bloomberg) -- Vietnam police detained the assistant to the head of the National Assembly over a...
Thermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call Transcript
Seeking Alpha· 5 hours agoThermo Fisher Scientific Inc. (NYSE:NYSE:TMO) Q1 2024 Earnings Call Transcript April 24, 2024 8:30 AM ETCompany ParticipantsRafael Tejada - VP, IRMarc...
Should You Pick Abbott Stock At $105 After An Upbeat Q1?
Forbes· 3 days agoAbbott (NYSE: ABT) recently reported its Q1 results, with revenues above and earnings exceeding our...
OSHA Puts Healthcare Employers on Alert After Issuing Penalties for Willful Citations
The National Law Review· 7 days agoAn alarm bell has sounded for healthcare facilities as the Occupational Safety and Health Administration (OSHA) issues two Willful COVID-19 Citations with nearly $300,000 in proposed penalties ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 hours agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation (“QuidelOrtho” or “the Company”) (NASDAQ: QDEL ...
Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
Insider Monkey via Yahoo Finance· 5 days agoPolen Capital, an investment management company, released its “Polen Focus Growth Strategy” first...
Roche Q1 Sales Down, Confirms FY24 View; Stock Down
RTT News· 11 hours agoShares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook.
Is Thermo Fisher Scientific (TMO) Trading at Attractive Valuations?
Insider Monkey via Yahoo Finance· 5 days agoPolen Capital, an investment management company, released its “Polen Focus Growth Strategy” first...